ResearchGate and the International Institute of Anticancer Research (IIAR) have established a Journal Home partnership to expand readership and engagement with IIAR’s open access journals.
The agreement covers four titles—Anticancer Research, In Vivo, Cancer Genomics & Proteomics, and Cancer Diagnosis & Prognosis. Full-text articles from these journals will be available on ResearchGate’s platform, which reaches over 25 million researchers.
The collaboration aims to enhance visibility and citations while providing new services for authors. Articles will be automatically added to author profiles, enabling tracking of readership and citations, and offering opportunities for direct engagement with readers. Journal-specific profiles will also raise brand awareness and strengthen connections with the research community.
The partnership builds on existing engagement with IIAR titles and seeks to broaden their reach beyond core markets in Japan, the United States, and Europe. By leveraging ResearchGate’s global network, IIAR expects to attract new authorship and increase the impact of its cancer research portfolio.
Click here to read the original press release.
